Piperonyl butoxide, alpha-[2-(2-butoxy-ethoxy)ethoxy]-4,5-methylenedioxy-2-
propyltoluene, is a widely used pesticide-synergist. Recently, results were
reported indicating that piperonyl butoxide is a hepatocarcinogen in rat.
Since the underlying mechanism was not elucidated, we examined the effects
on rat liver cells in detail. For this purpose male F344 rats were administ
ered piperonyl butoxide mixed in the diet at concentrations of 0 (negative
control), 0.05, 0.2 or 2% for 2 days, 1, 2, and 4 weeks. As a positive cont
rol, phenobarbital was administered to rats for up to 4 weeks as a 0.1% sol
ution in the drinking water. Increased liver weight, centrilobular hepatoce
llular hypertrophy due to increased smooth endoplasmic reticulum, decreased
numbers and areas of connexin 32-positive spots per hepatocyte, and increa
sed cell proliferation were observed in rats treated with 0.2 and 2% pipero
nyl butoxide. Similar results were obtained for 0.1% phenobarbital treated
rats. Hepatocellular necrosis suggestive of hepatotoxicity was also observe
d in the 2% piperonyl butoxide group. These results indicate that the promo
ting mechanism of piperonyl butoxide in hepatocarcinogenesis is similar to
that of phenobarbital, involving an ability to induce CYP isoenzymes and in
hibit gap junctional intercellular communication. In addition, increased ce
ll proliferation following hepatocellular necrosis may also play a role at
high doses.